Login / Signup

Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial.

C-W ParkS-J LimY-W MoonS-H ChoiM-H ShinY-K MinByung Koo YoonY-S Park
Published in: Climacteric : the journal of the International Menopause Society (2022)
MHT might not differ from risedronate in the prevention of secondary fractures and death among postmenopausal women with recent hip fracture.
Keyphrases
  • hip fracture
  • clinical trial
  • bone mineral density
  • phase ii
  • open label
  • study protocol
  • double blind
  • stem cells
  • phase iii
  • bone marrow